| Trial ID: | L2942 |
| Source ID: | NCT02048189
|
| Associated Drug: |
Levemir
|
| Title: |
Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes
|
| Acronym: |
TRICIDIA
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy
|
| Interventions: |
DRUG: LEVEMIR|DRUG: APIDRA
|
| Outcome Measures: |
Primary: Mixed measurement of insulin secretion and insulin resistance, Change from baseline insulin secretion and insuline resistance at 6 month after starting the treatment | Secondary: Decrease in the time spent in baseline and prandial hyperglycemia, During the 6 months following initiation of the treatment
|
| Sponsor/Collaborators: |
Sponsor: Centre Hospitalier Universitaire Dijon
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-03-08
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2024-02-21
|
| Locations: |
CHU de Besancon, Besancon, 25000, France|CHU de Dijon, Dijon, 21079, France
|
| URL: |
https://clinicaltrials.gov/show/NCT02048189
|
